As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Featured article: NICE guideline on thyroid disease - where does it take us with liothyronine?
In this commentary by Graham P. Leese, the author provides an overview of liothyronine as directed by the NICE guidelines.
Articles
-
-
Kinetic analysis of the growth rate of sporadic and hereditary medullary thyroid carcinoma: comparing the postoperative calcitonin-doubling rate with the hypothetical preoperative tumor volume-doubling rate
-
Teprotumumab: a disease modifying treatment for graves’ orbitopathy
-
Antithyroid drugs and birth defects
-
Macrofollicular variant of papillary thyroid carcinoma with metastasis to femur
-
The thyroid gland and the process of aging; what is new?
-
Assessment of Japanese iodine intake based on seaweed consumption in Japan: A literature-based analysis
-
The mechanisms of atrial fibrillation in hyperthyroidism
-
Hashimoto thyroiditis is more frequent than expected when diagnosed by cytology which uncovers a pre-clinical state
-
Spectrum of lithium induced thyroid abnormalities: a current perspective
Thank you!
Click here to read a heartfelt thank you to Professor Andrzej Lewinski for his years of service to Thyroid Research, written by EIC Bijay Vaidya.
Aims and scope
Thyroid Research is an online journal that aims to present the newest knowledge related to thyroid hormones, thyroid diseases and any related fields. The journal’s regular readership includes researchers, clinicians and healthcare providers across the world.
Thyroid Research encompasses a wide range of thyroidology topics including, diagnosis, pharmacological and other treatment methods, invasive treatment, physiological mechanisms of thyroid hormone action and regulation, immunological aspects, genetics, new guidelines in disease management, thyroid related diseases and complications.
Prof Bijay Vaidya, Editor-in-Chief
Bijay Vaidya is Consultant Endocrinologist at the Royal Devon & Exeter Hospital, and Honorary Clinical Professor at the University of Exeter Medical School, United Kingdom. He obtained his MBBS degree from the Darbhanga Medical College, Darbhanga, India and a PhD from the University of Newcastle upon Tyne, United Kingdom.
He has clinical and research interest in thyroid diseases, particularly thyroid disorders in pregnancy. He has served as Treasurer and an Executive Committee Member of the British Thyroid Association, and is a member of the Clinical Committeee of the UK Society for Endocrinology and the Thyroid Eye Disease Amsterdam Declaration Implementation Group UK (TEAMeD UK). He has served on the ETA Guidelines Task Forces for ‘Non-autoimmune hyperthyroidism due to TSHR mutations’ and ‘Subclinical hypothyroidism in pregnant women and children’ and the Royal College of Physicians Guidelines Task Force for ‘Management of Thyroid Eye Disease’.
Prof Vaidya has co-authored over 100 papers in peer-reviewed journals.
Annual Journal Metrics
-
Speed
37 days to first decision for reviewed manuscripts only
36 days to first decision for all manuscripts
97 days from submission to acceptance
11 days from acceptance to publication
Citation Impact
0.979 - Source Normalized Impact per Paper (SNIP)
0.565 - SCImago Journal Rank (SJR)
2.600 - CiteScore
Usage
206,597 Downloads
17 Altmetric mentions
